Emil J Freireich, M.D., Oral History Interview Session 01, October 5, 2011
Loading...
Description
Major Topics Covered:
- Personal and educational background
- Research: the continuous flow-blood separator; innovations in chemotherapy
- Collaboration with Dr. Emil Frei, III
- Building the research culture and training researchers at MD Anderson
- History of cancer medicine, clinical research, translational research and education
- MD Anderson presidents and the history and expansion of MD Anderson
Interview Chapters
Chapter 01: A New Idea and A Controversy: Transfusing Platelets in Leukemia Patients
Chapter 02: Building the Continuous-Flow Blood Separator
Chapter 04: MD Anderson Changes Under Charles LeMaistre: Expansions in Leukemia Research
Chapter 05: New Chemotherapy Treatments for Breast and Cultural Challenges to Research Innovation
Identifier
FreireichEJ_01_20110802
Publication Date
10-5-2011
Publisher
The Historical Resources Center, The Research Medical Library, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Freireich, Emil J. MD and Rosolowski, Tacey A. PhD, "Emil J Freireich, M.D., Oral History Interview Session 01, October 5, 2011" (2011). Interview Sessions. 4.
https://openworks.mdanderson.org/mchv_interviewsessions/4
Conditions Governing Access
Open
About the Interview
Dr. Emil J Freireich (b. 16 March 1927, in Chicago, Illinois) came to MD Anderson in 1965 to serve as Chief of Research (Hematology) in the Department of Development Therapeutics.
Dr. Freireich is best known for developing an effective treatment for childhood acute lymphoblastic leukemia, effectively curing that disease. Very early his research proved value of combination therapies. He served as head of Developmental Therapeutics from 1972-1983, when he became Chairman of the Department of Hematology. Since 1985, he has served as Director of the Adult Leukemia Research Program.